cytarabine has been researched along with phosphoserine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergmann, J; Brachwitz, H; Langen, P; Thomas, Y | 1 |
Andreeff, M; Champlin, RC; Dong, J; Estey, EH; Estrov, Z; Jiang, S; Konopleva, M; Kornblau, SM; Okcu, MF; Reed, JC; Sanchez-Williams, G; Snell, VE; Xie, Z; Zhang, X; Zhao, S | 1 |
Hu, ZB; McCulloch, EA; Minden, MD; Stahl, J | 1 |
Piwnica-Worms, H; Zhao, H | 1 |
4 other study(ies) available for cytarabine and phosphoserine
Article | Year |
---|---|
Opposite effects on cytosolic Ca2+ of antitumor phospholipids by induction of calcium influx and activation of endoplasmic reticulum Ca(2+)-ATPase.
Topics: Antineoplastic Agents; Breast; Calcium; Calcium-Transporting ATPases; Cell Division; Cell Line, Transformed; Cytarabine; Cytosol; Endoplasmic Reticulum; Enzyme Activation; Epithelial Cells; Female; Humans; Ion Transport; Lysophospholipids; Manganese; Phosphorylcholine; Phosphoserine; Signal Transduction; Structure-Activity Relationship | 1998 |
Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.
Topics: Acute Disease; Antigens, CD34; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; bcl-X Protein; Carrier Proteins; Cytarabine; Down-Regulation; Flow Cytometry; Gene Expression; Genes, bcl-2; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Neoplasm, Residual; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Survival Rate; Tretinoin; Tumor Cells, Cultured | 1999 |
Regulation of drug sensitivity by ribosomal protein S3a.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cryopreservation; Cytarabine; DNA Replication; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Gene Targeting; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Neoplasm Proteins; Neoplastic Stem Cells; Paclitaxel; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Rats; Ribosomal Proteins; Tissue Preservation; Treatment Outcome; Tretinoin | 2000 |
ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.
Topics: Adenoviridae; Amino Acid Motifs; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Caffeine; Cell Cycle; Cell Cycle Proteins; Cell Line; Checkpoint Kinase 1; Cisplatin; Cytarabine; DNA Damage; Enzyme Activation; Etoposide; Genes, Reporter; Humans; Hydroxyurea; Immunoblotting; Nucleic Acid Synthesis Inhibitors; Phosphodiesterase Inhibitors; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphoserine; Protein Kinases; Protein Serine-Threonine Kinases; Recombinant Fusion Proteins | 2001 |